Table 1.
Patient demographics (n = 12)
| n (%) | |
|---|---|
| Female | 6 (50.0%) |
| Age in years, mean (range) | 56.0 (39 to 77) |
| Race | |
| White | 6 (50.0%) |
| Black | 3 (25.0%) |
| Other | 3 (25.0%) |
| Ethnicity: Hispanic | 1 (8.3%) |
| Tumor Type | |
| MSS Colorectal Cancer | 7 (58.3%) |
| Appendiceal Cancer | 2 (16.7%) |
| Pancreatic Cancer | 1 (8.3%) |
| Endometrial Cancer | 1 (8.3%) |
| Salivary Gland Cancer | 1 (8.3%) |
| De novo metastatic at diagnosis | 6 (50.0%) |
| Cancer Treatment | |
| Prior number of regimens, mean (range) | 4.2 (1 to 8) |
| Patients with Prior Immunotherapy | 6 (50.0%) |
| Patients on maintenance chemotherapy | 1 (8.3%) |
n (%) unless otherwise stated; MSS, microsatellite stable